![Page 1: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/1.jpg)
Pharmaceutical Copolymer Excipient
Characterization by SEC/GPC-FTIR
William W. Carson; David Dunn; Jim Dwyer;
Ming Zhou; Tom Kearney
Spectra Analysis Instruments, Inc.
June 20, 2010
Contact: [email protected]
1
HPLC 2010 Boston: P2062T
![Page 2: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/2.jpg)
LC-IR Hyphenation
![Page 3: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/3.jpg)
Direct Deposition FTIR withDots (HPLC-IR) and Narrow Films (GPC-IR)
![Page 4: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/4.jpg)
Direct Deposition FTIR &
Data Processing (GPC-IR)
![Page 5: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/5.jpg)
GPC-IR Hyphenated Technology: 3D Plot
to Map out Polymer Compositions with Sizes
5
![Page 6: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/6.jpg)
Excipient Characterization by GPC-IR
6
Copolymer Compositional Analysis with MW Distributions
• Comonomer Ratio Drift (Functional Groups) vs. Bulk Average
• Excipient Lot-to-Lot Variations: QbD Studies
Excipient Performance & Functional Group Correlations
• Hydrophobic/Hydrophilic Ratio Drift vs. Phase Separations
• Effects on Excipient Dissolution Behavior
Reference
(1) Chemical Heterogeneity on Dissolution of HPMC,
EU J. of Pharma Sci., P392 (2009), A. Viriden et al.
(2) Comp Drift Effect on Dissolution of PMMA/MAA,
Materials Letters, P1144 (2009), E. Manias et al.
![Page 7: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/7.jpg)
IR Spectrum of Copovidone Excipient –
VP/VAc Copolymer from GPC-IR
Peak 1680 cm-1 from VP comonomer
Peak 1740 cm-1 from VAc comonomer
![Page 8: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/8.jpg)
GPC-IR Chromatogram Overlay with Comonomer Ratios
Excipient Compositional Drift (IR Peak Ratios)
with MWD Vs. Bulk Average
Abs. Peak Ratio: AVA / AVP = (k1*b*MVA) / (k2*b*MVP) = k (MVA / MVP) ~ Comonomer Ratio
(Molecular Weight Distribution)
Bulk Average
Copovidone
![Page 9: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/9.jpg)
0
.1
.2
.3
.4
.5
.6
106 104 103 102105
ma
x. IR
ab
so
rba
nce
Molecular Weight
Copovidone: sample A
30
35
40
45
50
molecular weight
distribution
% a
ceta
te c
om
onom
er
comonomer composition
distribution
Excipient Compositional Drift (%VAc)
with MWD Vs. Bulk Average
Bulk Average
40% VAc
![Page 10: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/10.jpg)
0
.1
.2
.3
.4
.5
.6
106 104 103 102105 Molecular Weight
Copovidone: sample A
30
35
40
45
50 % a
ceta
te c
om
onom
er
Comonomer Composition
Distribution
sample B
sample C
0
.1
.2
.3
.4
.5
.6
106 104 103 102105
sample B
sample C
Bulk 40% VAc
ma
x. IR
ab
so
rba
nce Molecular Weight
Distribution
Copovidone Compositional Drifts (%VAc)
from Different Manf. Processes
Copovidone A gave clear tablets while Copovidone C led to cloudy ones.
![Page 11: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/11.jpg)
IR Spectrum Difference of Two Grades of HPMC
(Type 2910 & 2208) from GPC-IR
OH
CH2
HP
CH3OCH3
CH2
-C-O-C-
![Page 12: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/12.jpg)
HPMCAS Grade-to-Grade
Difference (LF, MF, HF) by GPC-IR
M
OCH3
2830
C/HP
OH
3470
HP
CH3
1372
A
Acetyl
1235
AS
C=O
1740
HOOC-CH2-CH2-C=O
CH3-C=O
-C-O-C-Backbone
Ether
1060
![Page 13: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/13.jpg)
IR Band Identifications of HPMCAS Excipient
CH3-C=O
HOOC-CH2-CH2-C=O
Groups HP M C A AS Notes
CH3 1372 HP
OCH3 2830 M
OH 3470 (Unsub. OH & HP OH) OH
COCH3 1235 A
Total C=O 1740 AS
CH2 2935 2935 2935 2935 CH2
C-O-C 1060 BackBone
(BB)
![Page 14: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/14.jpg)
GPC-IR Chromatograph & Spectra of
HPMCAS Sample
![Page 15: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/15.jpg)
GPC-IR Chromatogram Overlay at
Different Wavenumbers of 2 HPMCAS Samples
ES1:
1060 cm-1
2834 cm-1
2838 cm-1
2935 cm-1
SE2:
1060 cm-1
2834 cm-1
2838 cm-1
2935 cm-1
![Page 16: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/16.jpg)
Acetyl/Backbone Ratio Drifts of 2 HPMCAS
Samples with Elution Time (MWD)
ES1SE2
![Page 17: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/17.jpg)
Total C=O AS / Backbone Ratio Drifts of 2 HPMCAS
Samples with Elution Time (MWD)
SE2
ES1
![Page 18: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/18.jpg)
To Find Succinic Acid Level on Backbone
(AS/Backbone)- k (A/Backbone) => S / Backbone
Absorptivity Ratio k
Needs to be Calibrated
from Known Standards
AS / BB Ratios
A / BB Ratios
ES1
SE2
ES1
SE2
![Page 19: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/19.jpg)
HP/Backbone Ratio Drifts of 2 HPMCAS
Samples with Elution Time (MWD)
ES1
SE2
![Page 20: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/20.jpg)
Total OH/Backbone Ratio Drifts of 2 HPMCAS
Samples with Elution Time (MWD)
ES1
SE2
![Page 21: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/21.jpg)
To Find Unsubstituted OH on Backbone
(OH/Backbone)- k (HP/Backbone) => Unsub. OH / Backbone
Absorptivity Ratio k Needs to be Calibrated from
Known Standards
SE2
ES1
ES1
SE2
HP / BB Ratios
OH / BB Ratios
![Page 22: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/22.jpg)
Methoxy / Backbone Ratio Drifts of 2 HPMCAS
Samples with Elution Time (MWD)
SE2
ES1
![Page 23: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/23.jpg)
2935cm-1 CH2 / Backbone Ratio Drifts of
2 HPMCAS Samples with Elution Time (MWD)
ES1
SE2
![Page 24: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/24.jpg)
2935 CH2 / BB & 2935 CH2 / AS Ratio Drifts of 2
HPMCAS Samples with Elution Time (MWD)
SE2
ES1
ES1
SE2
Peak 2935 / AS
Peak 2935 / BB
![Page 25: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/25.jpg)
Small HP/AS Ratio Drifts of 2 HPMCAS Samples
with Elution Time (MWD)
ES1
SE2
![Page 26: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/26.jpg)
Backbone/AS & HP/AS Ratio Drifts of 2 HPMCAS
Samples with Elution Time
SE2
ES1
SE2
ES1
BB / AS
HP / AS
![Page 27: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/27.jpg)
OH/AS Ratio Drifts of 2 HPMCAS Samples with
Elution Time (MWD)
SE2
ES1
![Page 28: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/28.jpg)
Methoxy/AS C=O Ratio Drifts of
2 HPMCAS Samples with Elution Time (MWD)
SE2
ES1
![Page 29: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/29.jpg)
Acetyl/AS C=O Ratio Drifts of
2 HPMCAS Samples with Elution Time (MWD)
SE2
ES1
0.52 ---- MF
0.40 ---- LF
Grade
Levels
![Page 30: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/30.jpg)
Methoxy/2935 CH2 & Methoxy/Backbone Ratio
Drafts of 2 HPMCAS Samples with Elution Time
M / 2935 CH2
M / BB
ES1
SE2
ES1
SE2
![Page 31: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/31.jpg)
Methoxy / Acetyl Ratio Drafts of
2 HPMCAS Samples with Elution Time (MWD)
ES1
SE2
![Page 32: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/32.jpg)
Summary: Compositional Differences
of 2 HPMCAS Samples
32
Sample # Sample
Appearance
Compositional Drifts
w/ MWD
Consistent
Substitution
w/ MWD
ES1 Fine
Powder
Methoxy,
Acetyl / Succinate,
Hydroxyl, CH2
HP
SE2 Fine
Powder
Methoxy,
Acetyl / Succinate,
Hydroxyl, CH2
HP
Difference
Different Drift Patterns
with Methoxy,
Acetyl / Succinate,
Hydroxyl, CH2
Little
Difference
with HP
![Page 33: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/33.jpg)
GPC-IR Chromatogram Overlay
at 1739 cm-1 of 4 HPMCAS-MF Lots
T8 T10 T12 T14 Snapshots
![Page 34: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/34.jpg)
Acetyl/TotalEster Ratio Drifts of 4 MF Lots
Compared to LF & HF HPMCAS
-- LF ---------
-- HF ---------
![Page 35: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/35.jpg)
GPC-IR Conclusions
GPC-IR Takes Snapshot IR Pictures of Polymer Excipients
for Compositional Drifts with MW Distributions
Many Ways to Analyze Functional Group Drifts w/ MWD:
Group vs. Backbone, Various Ratios among Groups, etc.
Useful to Characterize Lot-to-Lot, Grade-to-Grade and
Supplier-to-Supplier Variations of Polymeric Excipients
Understand Excipient Manufacturing Variables and QC
GPC-IR is a Powerful Tool to Analyze Compositional
Variations of Copolymers across MWD
![Page 36: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/36.jpg)
Common Polymeric Excipients
36
Neutral Cellulose Derivatives
• HydroxyPropyl Methoxy Cellulose (Hypromellose): HPMC
• HydroxyPropyl Cellulose: HPC
• Cellulose Acetate Butyrate: CAB
Acidic Cellulose Derivatives
• HPMC Acetate Succinate: HPMC-AS
• HPMC Phthalate: HPMC-P
• Cellulose Acetate Phthalate: C-A-P
Copovidone: PolyVinyl Pyrrolidone / Vinyl Acetate – PVP/VAc
SoluPlus Terpolymer: PEG / PCL / PVAc
Methacrylate Copolymers: Eudragit
Polyethylene Oxide: PEO (MW > 20K) or PEG (MW < 20K)
Excipient Combinations with Plasticizers and Additives
![Page 37: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/37.jpg)
Excipient Analysis with LC-IR
in Drug Formulations
• Polymeric Excipient Characterization
• Degradation in Process (Hot Melt Extrusion)
• Excipient / API Interactions
• Forced Degradation in Shelf Life Study
December 1, 2008: Vol. 5, No. 6
The cover cartoon illustrates a solid dispersion assembly that is
composed of entangled polymer chains with drug molecules
embedded in the form of single molecule, small clusters, and/or
large aggregates (amorphous).
![Page 38: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/38.jpg)
GPC-IR Applications for Excipient Analysis
in Drug Formulations
Excipient
Manufacturing
• Process Control
• Lot-to-lot Variations
• CoA
• Novel Excipient R&D
• Trouble Shooting
Formulation Develop. Drug Manufacturing
• Incoming QC
• Excipient Functionality
• Formulation Development
• QbD
• Process Degradation (Hot Melt Extrusion)
• Define Safe Process Window / QbD
• Process Monitoring
• Trouble Shooting
Formulated Drugs
Shelf Life Stability
• Stressed Degradation
• De-Formulate Excipient Blends
• Trouble-Shoot Problem Drugs in the Market
Users: Excipient Pharma Co. Pharma Co.
Manufacturers HME Service Providers Generic Drug Co.
![Page 39: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/39.jpg)
Excipient QbD Space
GPC-IR-Performance
Slide from USP International Excipient Workshop (July 2009)
GPC
IR
Performance
![Page 40: HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR](https://reader034.vdocument.in/reader034/viewer/2022042516/55930e391a28ab05318b46f4/html5/thumbnails/40.jpg)
GPC-IR & HPLC-IR Applications
Excipient Characterization, Functionality & Degradation Analysis
Copolymer Compositional Analysis across MW Distribution
Polyolefin Copolymer Branching Analysis by High Temp GPC-IR
Polymer Blend Ratio Analysis across MW Distribution
Polymer Additive & Impurity Analysis
De-Formulation for Polymers and Additives: Competitive Analysis
Process Control & Optimization
Excipients, Plastics, Rubbers, Films, Fibers, Foams & Composites
Reactive Polymer Analysis for Coating, Adhesive, Sealant & Elastomer
Isomer Analysis for Chemicals, Forensics & Pharmaceuticals
General Analytical Capability: Trouble Shooting
40